laurdan has been researched along with piroxicam in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saini, MK; Sanyal, SN | 1 |
| Gąsiorowska, J; Maniewska, J; Michalak, K; Szczęśniak-Sięga, B | 1 |
2 other study(ies) available for laurdan and piroxicam
| Article | Year |
|---|---|
Piroxicam and c-phycocyanin prevent colon carcinogenesis by inhibition of membrane fluidity and canonical Wnt/β-catenin signaling while up-regulating ligand dependent transcription factor PPARγ.
Topics: 2-Naphthylamine; Animals; Apoptosis; Calcium; Calpain; Carcinogenesis; Colonic Neoplasms; Fluorescence Polarization; Fura-2; Intracellular Space; Laurates; Ligands; Male; Membrane Fluidity; Membrane Potentials; Phase Transition; Phosphatidylethanolamines; Phycocyanin; Piroxicam; PPAR gamma; Pyrimidinones; Rats, Sprague-Dawley; Up-Regulation; Wnt Signaling Pathway | 2014 |
The interaction of new oxicam derivatives with lipid bilayers as measured by calorimetry and fluorescence spectroscopy.
Topics: 1,2-Dipalmitoylphosphatidylcholine; 2-Naphthylamine; Anti-Inflammatory Agents, Non-Steroidal; Calorimetry; Laurates; Lipid Bilayers; Molecular Structure; Piroxicam; Spectrometry, Fluorescence; Thiazines | 2018 |